Dr. Sonya VanPatten is a research scientist in the Institute of Molecular Medicine at the Feinstein Institutes for Medical Research.
Dr. VanPatten received her PhD from the Albert Einstein College of Medicine (Bronx, NY, USA) in the Department of Biochemistry. She later did a post-doc at the Feinstein Institutes in the Department of Medicinal Chemistry. Dr. VanPatten’s research has been in the fields of lipid metabolism, obesity, immunology and autoimmune disease, neuroscience, and drug discovery and development. Currently, she focuses on scientific writing, synopsis, consultation, project management, and editorial aspects of the Institutes’ journals.